中文 | English
Return
Total: 45 , 1/5
Show Home Prev Next End page: GO
Author:(Yea Eun KANG)

1.Development of Metabolic Synthetic Lethality and Its Implications for Thyroid Cancer

Sang-Hyeon JU ; Seong Eun LEE ; Yea Eun KANG ; Minho SHONG

Endocrinology and Metabolism 2022;37(1):53-61

3.Toward Systems-Level Metabolic Analysis in Endocrine Disorders and Cancer

Aliya LAKHANI ; Da Hyun KANG ; Yea Eun KANG ; Junyoung O. PARK

Endocrinology and Metabolism 2023;38(6):619-630

4.The Role of Circulating Slit2, the One of the Newly Batokines, in Human Diabetes Mellitus.

Yea Eun KANG ; Sorim CHOUNG ; Ju Hee LEE ; Hyun Jin KIM ; Bon Jeong KU

Endocrinology and Metabolism 2017;32(3):383-388

5.Treatment with Gefitinib, an Epidermal Growth Factor Receptor Inhibitor, Decreases Serum Cholesterol in Patients with Lung Cancer

Yea Eun KANG ; Ji Min KIM ; Kyong Hye JOUNG ; Hyun Jin KIM ; Bon Jeong KU

Korean Journal of Obesity 2016;25(4):233-239

6.Regulation of Systemic Glucose Homeostasis by T Helper Type 2 Cytokines

Yea Eun KANG ; Hyun Jin KIM ; Minho SHONG

Diabetes & Metabolism Journal 2019;43(5):549-559

8.Prognostic Significance of Sirtuins Expression in Papillary Thyroid Carcinoma

Yea Eun KANG ; Minho SHONG ; Jin Man KIM ; Bon Seok KOO

International Journal of Thyroidology 2018;11(2):143-151

10.Metabolic Reprogramming in Thyroid Cancer

Sang-Hyeon JU ; Minchul SONG ; Joung Youl LIM ; Yea Eun KANG ; Hyon-Seung YI ; Minho SHONG

Endocrinology and Metabolism 2024;39(3):425-444

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 45 , 1/5 Show Home Prev Next End page: GO